Načítá se...
Indomethacin for symptomatic patent ductus arteriosus in preterm infants
BACKGROUND: Symptomatic patent ductus arteriosus (PDA) is associated with mortality and morbidity in preterm infants. In these infants, prophylactic use of indomethacin, a non‐selective cyclooxygenase inhibitor, has demonstrated short‐term clinical benefits. The effect of indomethacin in preterm inf...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2021
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095061/ https://ncbi.nlm.nih.gov/pubmed/33448032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013133.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|